Document Detail

Transcatheter occlusion of the patent ductus arteriosus in infants - experimental testing of a new amplatzer device.
MedLine Citation:
PMID:  21234918     Owner:  NLM     Status:  Publisher    
OBJECTIVES:: This study assessed the feasibility and efficacy of implanting a new miniaturized nitinol device to occlude the patent ductus arteriosus (PDA) in a newborn porcine model. BACKGROUND:: Transcatheter device closure is the standard of care for PDA in older children and adults. Currently available technology is not designed for the newborn infant. METHODS: The Amplatzer Duct Occluder II 0.5 is a new transcatheter Nitinol device without fabric designed to close the PDA with small aortic and pulmonary artery structures. The device was implanted in 8 infant pigs (average weight 2400 gm) after balloon dilation of PDA (average diameter 2.7mm, average length 5.8mm) with immediate, ∼7, ∼30 and ∼90 day follow-up by echocardiography, angiography and final pathological examination. Half were implanted arterial, and half venous. RESULTS:: The device was successfully implanted in all animals. There was complete occlusion of the PDA in all cases without obstruction of the pulmonary arteries or aorta. There was complete late endothelialization without thrombus. The only complication was transection of a femoral artery accessed by cutdown. CONCLUSIONS: The success of this animal study confirms safety and feasibility of the Amplatzer Duct Occluder II 0.5 (now known as the ADO II AS) for use when the aorta and pulmonary arteries are small. Consideration can be given to transcatheter closure of the PDA in preterm and other small infants with this device. © 2011 Wiley-Liss, Inc.
John L Bass; Neil Wilson
Related Documents :
21138278 - Viruses in pharmaceutical research: pulmonary vascular disease.
21162968 - Percutaneous valve stent insertion to correct the pulmonary regurgitation: an animal fe...
20500438 - Two cases of idiopathic infantile arterial calcification.
25395858 - Congenital anomaly of the inferior vena cava and factor v leiden mutation predisposing ...
16189698 - Renal artery changes in patients with primary renal cell carcinoma.
7448658 - Transluminal dilatation in the treatment of peripheral arterial occlusive disease.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-1-13
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  -     ISSN:  1522-726X     ISO Abbreviation:  -     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2011-1-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
University of Minnesota Amplatz Children's Hospital, Minneapolis MN.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Successful subxyphoid hybrid approach for placement of a melody percutaneous pulmonary valve.
Next Document:  A randomized comparison of manual versus mechanical thrombus removal in primary percutaneous coronar...